Repositioning of a Cyclin-Dependent Kinase Inhibitor GW8510 as a Ribonucleotide Reductase M2 Inhibitor to Treat Human Colorectal Cancer

Cell Death Discovery - United Kingdom
doi 10.1038/cddiscovery.2016.27
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Preliminary Crysallization of a Cyclin-Dependent Kinase Inhibitor: P18

Acta Crystallographica Section A Foundations of Crystallography
1996English

A Cyclin-Dependent Kinase Inhibitor, Dinaciclib in Preclinical Treatment Models of Thyroid Cancer

PLoS ONE
Multidisciplinary
2017English

Interferon‑β Sensitizes Human Glioblastoma Cells to the Cyclin‑dependent Kinase Inhibitor, TG02

Oncology Letters
Cancer ResearchOncology
2020English

Crystal Structure of a Human Cyclin-Dependent Kinase 6 Complex With a Flavonol Inhibitor, Fisetin

2005English

Yeast Dun1 Kinase Regulates Ribonucleotide Reductase Inhibitor Sml1 in Response to Iron Deficiency

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2014English

The Cyclin-Dependent Kinase Inhibitor P27Kip1 Induces N-Terminal Proteolytic Cleavage of Cyclin A

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1998English

Cyclin-Dependent Kinase Inhibitor 2B Regulates Efferocytosis and Atherosclerosis

Journal of Clinical Investigation
Medicine
2019English

The Cyclin-Dependent Kinase Inhibitor Flavopiridol (Alvocidib) Inhibits Metastasis of Human Osteosarcoma Cells

Oncotarget
Oncology
2018English

Modulation of Apoptosis by the Cyclin-Dependent Kinase Inhibitor P27Kip1

Journal of Clinical Investigation
Medicine
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy